Description
Cartalax (also known as AED or AC-4) is a tripeptide complex (alanine-glutamic acid-aspartic acid) that modulates cartilage and bone metabolism by targeting cellular pathways in chondrocytes and thyroid C cells.
Cartalax is a synthetic tripeptide composed of alanine, glutamic acid, and aspartic acid. Its structure enables interaction with cellular mechanisms in cartilage (chondrocytes) and bone-regulating thyroid cells. The peptide may support joint health by promoting collagen production—a key structural protein in connective tissues—and reducing programmed cell death (apoptosis) in stressed cartilage cells. Its anti-inflammatory effects stem from inhibiting enzymes like matrix metalloproteinases that break down cartilage, while simultaneously curbing inflammatory signaling molecules. Cartalax also appears to influence calcium metabolism through thyroid C cells, potentially aiding bone density.
